-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
Belgium releases first results of the 2017 transparency reporting period
Nov 02, 2018
In June 2018, the Belgian government released the first results from the 2017 transparency reporting, mandated by the Belgian Sunshine Act. The law requires both pharmaceutical and medical device manufacturers to disclose interactions with healthcare professionals (HCPs), healthcare organizations (HCOs), and patient organizations (POs) whether for human or veterinary purposes.
Under the Belgian Sunshine Act, transparency obligations are now mandatory for all in-scope companies. Reports must be submitted for the previous calendar year by May 31st via the betransparent.be platform. Research and development spending reports may aggregate all R&D-related transfers of value; however, all other types of transfers of value, granted directly or indirectly, from Belgium or elsewhere must be reported for each covered entity.
The first results of the mandatory 2017 transparency reporting period have been published. Key figures include:
- 530 pharmaceutical and medical technology companies submitted transparency reports.
- 14,617 recipients are identified, including 11,800 HCPs and 2,600 HCOs.
- Together, Life Sciences companies spent €203,271,730 in 2017 in collaborations with HCPs and HCOs in Belgium. Relative to the 2015 and 2016 voluntary disclosure periods, this represents a 19% and 23% increase in total monies reported.
Thanks to the required fields of “type of spend” and “profession”, the public has a better insight into the relationship between industry and health care providers and organizations. Specifically, these collaborations can be divided and understood as follows:
Breakdown of Type of Spend: 2017 Reporting Period Belgian Sunshine Act
Transparency data shows scientific research accounts for 57% of industry spend, while specialist doctors account for 65% of referenced professions. Specialists in the fields of cardiology, internal medicine, and orthopedic surgery were referenced most frequently in 2017 data, while the professions of dentistry and medical imaging technologists were referenced the least. These figures clearly indicate the majority of industry funds were given to specialist doctors, devoted to scientific research. In a very distant second, we see Scientific Events receiving 19% of total funds.
Professions Most Referenced: 2017 Reporting Period Belgium Sunshine Act
To comply with the requirements of the Sunshine Act, companies must collect personal data of European HCPs, including their name, occupation, contact details, and unique government identifiers. Though it was previously mandatory to obtain an HCP’s consent under the voluntary industry association codes of EFPIA, the new legally binding requirement supersedes any industry codes.
Before the implementation of the Belgian Sunshine Act transparency obligations were only mandatory for member companies of EFPIA. During the period of voluntary disclosure, total amounts disclosed were:
- 2015 data disclosed in 2016: €138 million (Total amount disclosed)
- 2016 data disclosed in 2017: €170 million (Total amount disclosed)
From the date of entry into force of the Sunshine Act, companies are no longer required to obtain consent for disclosure of covered HCPs, HCOs and POs. Companies should, however, inform beneficiaries correctly about the publication, when collecting their personal details, in order to comply with both Belgium and GDPR data privacy requirements.
Understanding the complexity of the interplay between transparency reporting obligations and data privacy requirements is complex. IQVIA legal experts can take ownership and accountability for managing your journey toward full compliance. Our Aggregate Spend software provides a solution for meeting Belgian and global transparency reporting requirements. For further information, about our technology solution, please reach out to see how we can make transparency disclosure easy.
Source: https://www.betransparent.be/fr/communique-de-presse-les-entreprises-prestataires-de-soins- institutions-de-soins-et-organisations-de-patients-jouent-pleinement-la-carte-de-la-transparence/